Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 145

Results For "WHO"

2352 News Found

CHMP recommends European Commission approval of Rinvoq
Drug Approval | May 23, 2022

CHMP recommends European Commission approval of Rinvoq

Ulcerative colitis is a chronic, immune-mediated inflammatory bowel disease that can lead to substantial burden and often disability among patients


50% of the world's population expected to be myopic by 2050
News | May 23, 2022

50% of the world's population expected to be myopic by 2050

Researchers have found out that myopia often leads to an abnormal increase in axial length. When the axial length grows to more than 25mm, especially with age, problems like cataracts or glaucoma can appear


New study finds that Masimo PVi may be useful in helping ER doctors determine the severity of asthma attacks
Biotech | May 23, 2022

New study finds that Masimo PVi may be useful in helping ER doctors determine the severity of asthma attacks

Acute asthma attack is a common cause of admission to emergency departments (EDs) among children, and triage by severity is important for determining appropriate clinical treatment


SIMS Hospital conducts high-performance hip replacement surgery
Hospitals | May 21, 2022

SIMS Hospital conducts high-performance hip replacement surgery

The patient, who was previously diagnosed with osteoarthritis, was prescribed hip replacement surgery as the best and most effective solution for his condition


USFDA approves Dupixent as first treatment for 12 and older with eosinophilic esophagitis
Drug Approval | May 21, 2022

USFDA approves Dupixent as first treatment for 12 and older with eosinophilic esophagitis

Dupixent is the first and only medicine indicated to treat eosinophilic esophagitis in the United States; approval granted more than two months ahead of USFDA’s Priority Review action date


Novartis Cosentyx receives positive CHMP opinion for use in childhood arthritic conditions
Biotech | May 21, 2022

Novartis Cosentyx receives positive CHMP opinion for use in childhood arthritic conditions

Positive opinion could expand the role of Cosentyx (secukinumab) in reducing flare risk in pediatric enthesitis-related arthritis (ERA) and psoriatic arthritis (PsA) patients in the EU


AbbVie submits NDA for treatment of advanced Parkinson’s disease
Biotech | May 21, 2022

AbbVie submits NDA for treatment of advanced Parkinson’s disease

If approved, ABBV-951 will offer patients the first continuous subcutaneous delivery of carbidopa/levodopa prodrugs


Havas Health & You appoints Dan Rubin as President of Havas Health +
People | May 20, 2022

Havas Health & You appoints Dan Rubin as President of Havas Health +

Key senior hire will partner with Allison Ceraso, President and CCO, bolstering agency leadership amongst continued network momentum


Sparsh Hospital introduces ‘Infinite care’ joint replacement programme
Hospitals | May 20, 2022

Sparsh Hospital introduces ‘Infinite care’ joint replacement programme

‘Infinite Care’ comprises two key pillars - Sparsh Sankalpa and Sparsh Sukshema


Pharma companies with ESG more valuable say investors
Sustainability | May 20, 2022

Pharma companies with ESG more valuable say investors

When asked how to balance ESG with broader business goals, the panel was unanimous in its assessment that ESG is ‘good for business’